CVE-2021-33469

CVE-2021-33469 is a medium-severity vulnerability in Phpgurukul Covid19 Testing Management System with a CVSS 3.x base score of 4.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Description

COVID19 Testing Management System 1.0 is vulnerable to Cross Site Scripting (XSS) via the "Admin name" parameter.

Frequently asked questions

What is CVE-2021-33469?
COVID19 Testing Management System 1.0 is vulnerable to Cross Site Scripting (XSS) via the "Admin name" parameter.
How severe is CVE-2021-33469?
CVE-2021-33469 has a CVSS 3.x base score of 4.8, rated medium severity. It is exploitable over network with low attack complexity, requires high privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2021-33469 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (47th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2021-33469?
CVE-2021-33469 affects Phpgurukul Covid19 Testing Management System. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2021-33469?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2021-33469 published?
CVE-2021-33469 was published on 2021-05-26 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Phpgurukul Covid19 Testing Management System

All CVEs affecting Phpgurukul Covid19 Testing Management System →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →